Category: uncategorized

It is time for healthcare to transcend its traditional boundaries and embark on a new era of patient empowerment and collaboration, where adherence becomes a cornerstone of improved healthcare outcomes. The time for change is now.

Recognizing patients’ continuously evolving needs throughout their healthcare journey holds paramount importance. Mere acknowledgment of these needs falls short, while proactive, efficient, and continuous addressing of these needs is essential to overcome the numerous adherence barriers that hinder patients from accessing essential care. This underscores the urgent need to develop a transformative and all-encompassing solution customized to the broad spectrum of patients’ requirements. Such a solution must be guided by a scientific yet holistic approach to ensure effective development. 

The holistic approach to access to adherence acknowledges the multifaceted nature of a person’s life. It recognizes that effective treatment compliance requires a comprehensive understanding of the individual and their circumstances. By considering multiple factors based on the different methodologies that impact disease self-management, the holistic approach aims to promote patient-centric care and a personalized support model that helps individuals successfully overcome the barriers to healthcare.

Adherence to treatment is rooted in creating an environment where patients can thrive. By offering adherence to treatment solutions, we can undertake a holistic approach to create an ecosystem that can improve a patient’s life and encapsulate how patients cope with disease from the first signs and symptoms that they experience to throughout their full journey, thereby empowering them with all tools to be able to cope with a lifelong disease. This all-encompassing and thorough method acknowledges the interplay of diverse factors that impact an individual’s capacity to adhere to their healthcare provider’s advice. It extends beyond mere medication adherence and considers the broader environment in which the individual operates. 

Non-adherence to prescribed treatment can lead to suboptimal health outcomes such as disease progression, hospitalization, reduced quality of life, and serious or irreversible complications. Non-adherence increases the burden on health systems at a time when there are ever-greater demands on healthcare resources. A gap in patient adherence to treatment could collapse the healthcare ecosystem; thus, adherence support solutions are critical to achieving optimal medical outcomes.  

The traditional approach within the healthcare system has relied upon a limited range of interventions to foster patient adherence. Typically, patients are warned about the potential consequences of non-adherence, while standardized follow-up consultations are scheduled for the entire patient population. Unfortunately, this one-size-fits-all approach fails to account for individual patients’ unique circumstances and diverse needs. Consequently, billions of dollars are spent on interventions that may only be effective for some or unsustainable patient support programs.  

This emphasizes the need to innovate a multi-layered scientific approach to effectively address the World Health Organization’s (WHO) five dimensions of adherence. WHO defines adherence as “the degree to which the person’s behavior corresponds with the agreed recommendations from a healthcare provider.” It also adds that 80 percent or more adherence rates are typically needed for optimal therapeutic efficacy. But poor adherence to therapy is a significant public health problem, averaging only 50 percent in developed countries and even lower in developing countries. As outlined by WHO in its dimensions, patients’ therapeutic outcomes are affected by factors such as social and economic as well as therapy, disease, patient, and healthcare system-related factors. Therefore, we must draw inspiration from successful strategies that relevant industries, policymakers, regulators, researchers, and entrepreneurs employ to tackle this challenge. Given that each patient journey is unique – equitable, and sustainable, healthcare access solutions should be designed to address patient adherence challenges in a personalized way.  

Care and treatment extend beyond mere medication. The importance of establishing a patient-centric care ecosystem is more apparent than ever. Embracing a comprehensive, multi-dimensional view of each individual’s journey allows us to delve into their adherence support routines and the fundamental factors shaping their behaviors. This encompasses demographics, lifestyle decisions, and more. 

At Axios International, we look at the patient journey holistically and provide tailored, personalized adherence interventions for each patient because each is different. Adopting an evidence-based approach, our proprietary Patient Needs Assessment Tool (PNAT) customizes services to each patient, thereby increasing adherence, engagement, and program cost-efficiency​. The patient undergoes personal needs assessment using PNAT to determine the support they need, based on which a personalized Patient Support Program (PSP) is developed, resulting in improved medical outcomes.  

Only by utilizing the validated scientific tools to assess and identify the unmet needs of the patients in a customized approach and understanding the variations in patient adherence patterns and individual motivations can healthcare providers customize interventions to address the specific needs of patients who require additional support to maximize their medical benefit. For instance, one patient may discontinue therapy due to intolerable side effects, the inconvenience of doctor visits, and apprehension about being reprimanded for non-adherence. Conversely, another patient with the same diagnosis may frequently skip doses due to a demanding lifestyle, frequent travel, and a lack of comprehension regarding the severity of their condition. Recognizing these nuanced differences is pivotal in devising effective access strategies and solutions that cater to each patient’s needs. To provide care and treatment in the right place at the right time, a broad range of cost-competitive access to adherence solutions, including remote care and other support solutions, can ensure that patients and their families can access care and treatment services where and when they need the most.  

However, interventions alone are insufficient. All stakeholders, including the community, must embrace agility by creating an eco-system that encourages innovation in designing, executing, monitoring, and continuously evolving access solutions based on emerging unmet needs during a patient’s journey. Partnering with access to healthcare providers can also help track the effectiveness of interventions at both the individual and segment levels and help make improvements to enhance success rates. These improvements also necessitate collaboration across functions such as research and development, product development, medical, and patient services, while dedicated resources equipped with specialized skills in communications, technology, data analytics, quality, and compliance facilitate coordinated execution across all channels.  

Healthcare providers must adopt a 360-degree patient support approach to revolutionize patient adherence. By doing so, they can enhance adherence rates, curtail unsustainable practices in healthcare systems, and enhance quality of life by improving patient health and medical outcomes. Achieving this transformation demands the seamless integration of predictive analytics, personalized patient adherence interventions, and agile operational frameworks, all with the primary goal of empowering patients to engage in their healthcare journeys actively. The present moment beckons healthcare to transcend conventional confines and usher in a fresh era of patient empowerment and collaboration, where adherence is a cornerstone of better healthcare results. 

30th May 2023

Understanding a patient’s journey – prior to diagnosis all the way till after treatment – is pivotal to maximizing the potential of novel therapies and patient support services. In today’s world, the healthcare industry is leveraging real-world data to improve medical outcomes and discern this journey. Over the last decade, there has been significant growth in the availability of real-world data sources. However, more accurate data is needed to understand how specific access or patient support interventions affect patients’ health outcomes. Such data is vital for several reasons. It can help doctors make better decisions about a patient’s treatment, help healthcare providers optimize access to their medications and treatments, and help governments or other payers decide how to support the cost of treatment and determine the overall impact. The gathered data interests all stakeholders, and its insights help develop a sustainable healthcare ecosystem centered around patients. 

With 25 years of global experience and local expertise in implementing Patient Assistant Programs (PAPs) and Patient Support Programs (PSPs) to over 9.5 million patients in over 100 countries, Axios International is uniquely positioned to offer specialized solutions to address these challenges through Real World Insights. RWI is significant in identifying critical factors impacting patients’ health outcomes and ensuring that these insights are used to improve healthcare deliveries to support needy patients across emerging markets.   

Bridging the healthcare access gap through Real-World Insights   

RWI is the result of the core activities Axios International undertakes. It has been designed to draw learnings from the healthcare access initiatives implemented in over 100 countries and help Axios improve its existing programs to create better patient benefits and contribute towards better access. Through its daily work, Axios has access to insights and understanding of how a patient’s journey should differ from Malaysia to the United Arab Emirates (UAE) to Mexico. This information is analyzed systematically to understand how Axios can improve how it supports patients and, most importantly, contribute to broader access.   

The ability to comprehend these realities stems from the privilege of working closely with patients, their healthcare providers, and other stakeholders in their treatment journey, having developed a clear understanding that >70% of a patient’s journey happens once they leave the clinical settings. This experience allows us to gather insights that are safe and compliant with all privacy standards, such as the General Data Protection Regulation (GDPR) and any local privacy data laws applicable in the countries where Axios programs have been implemented, ensuring a compliant approach. Using the same process, Axios also ensures patients’ boundaries are considered. The focus is on providing data security while expanding patient access and using these insights only to support broader access. With RWI, we can systematically analyze, learn, and improve from our thousands of patient support and assistance programs and help demonstrate the value of the access initiatives.   

Ultimately, Axios International RWI’s scientific and patient-centric approach is to learn and identify potential affordability, care, and treatment accessibility barriers in the patient journey and improve the level of support provided through Axios access initiatives. These barriers can be overcome by understanding how to reach optimal treatment plans that suit the needs of the patients in the space outside the hospital or healthcare facility, increasing the rate of adherence to treatment, and ultimately, reducing the disease burden and strengthening the local healthcare landscape. It also helps shape how healthcare is delivered to patients wherever they are in a pragmatic patient-centric approach. In essence, RWI helps map out the entire patient journey unique to each patient, identify potential barriers, and improve the level of support through access initiatives across emerging markets.   

Space outside the hospital  

Working with patients since Axios launched the first anti-retroviral and cancer programs 25 years ago, one unique factor seen in every country is that most of the patients’ journey happens in space outside the hospital or healthcare facility. A patient sees the doctor and spends five or twenty minutes with a physician, depending on where they are in the world, and then goes home. That disease burden, for instance, having multiple treatments throughout the day, remains with the patient, the family, and the caregiver. RWI helps us understand what happens in that space outside the hospital and how to create a more connected healthcare system between the stakeholders to help improve treatment outcomes.  

Axios RWI outcomes from a recent study demonstrate a difference in the impact and duration of treatment of a patient and is an apt example of how the company contributes to shaping broader access. The study shows how the type of intervention done during follow-up may influence the patient’s ability to continue to take treatment; Axios RWI helped us learn that patients who received a phone call with a personalized touch ended up staying on treatment longer compared to digital-only follow-ups via apps or email. In this case, the impact of using digital as an enabler was demonstrated rather than as a tool to replace that human touch.   

Real-world, access-focused insights can aid in identifying the unmet needs of patient populations, improving the overall patient experience. In addition, access-focused data can help facilitate solutions by supporting evidence-based decision-making by all stakeholders involved in the treatment journey – from the patient who experiences the symptom to the doctor that first diagnoses and prescribes treatment to the patient, to the company that manufactures the therapy, to the government that decides how to make the treatment available to that population and develops best-in-class guidelines and policies.   

Enhancing the patient journey, Axios RWI further helps deliver breakthrough insights on the disease evolution, treatment, patients’ perceptions, outcomes, and costs. By creating 360-degree value through data from all stakeholders, RWI supports patients in achieving better health outcomes.   

18 May, 2023

Axios International has undergone a significant transformation since it was established in 1997. From its humble beginnings to its current status as a leading access to healthcare firm, Axios has demonstrated a relentless commitment to change and innovation. The company’s evolution and unwavering focus on never standing still, the impact of our actions on patients, and the challenges posed by our diverse global workforce make Axios what it is today. 

In 2009, Axios had a distinct organizational structure. It operated like a Professional Services (consultancy) firm with notable service lines and offices in the US, Europe, Africa and Asia. However, over the past 10 years, the organization has undergone a structural overhaul, shifting its focus towards implementation and diversifying its client base and program offerings. 

Between 2012 and 2014, Axios faced a fundamental shift that required us to reassess our direction to evolve while continuing to implement strategies and patient support programs. The company was expanding into the Middle East and had started looking at its access solutions from a 360-degree angle. The company’s contraction necessitated stretching capacities and adapting to new challenges. This period of transformation allowed the company to go beyond the traditional boundaries, encouraging everyone to explore diverse roles and contribute to various departments within the organization.  

#NeverStandingStill: 

One of the most striking aspects of working at Axios is the company’s focus on never standing still and embracing change to always find a solution. This agile approach enables us to implement changes quickly without dwelling on complex bureaucratic procedures. Although challenges and pushback are not uncommon, the pace and open-mindedness of Axios foster a dynamic work environment. 

The philosophy of never standing still also translates into tangible health outcomes for patients. Axios constantly drives change and maintains a patient-centric focus, ensuring treatments remain uninterrupted and patients receive the support they need. Even during the challenging COVID-19 pandemic, Axios employees demonstrated an unwavering commitment, going above and beyond to serve patients by embodying the spirit of “leave no patient behind.” The passion and dedication exhibited by our global workforce had a profound impact during this time, and the organization’s flexibility and adaptability were critical in navigating the crisis. 

Axios is a complex organization because of its geographical footprint and presence in several countries. With 40 different nationalities represented within Axios in 20 different countries, the diverse workforce presents unique opportunities. Effective communication and collaboration across multiple time zones and cultures require a mindful and tailored approach. Understanding and respecting the distinct Axios’ experiences of employees in various locations is crucial, as different regions may have different rhythms, routines, and ways of doing things. Balancing the need for clear communication while adapting messages to suit different audiences remains an ongoing challenge. 

While being at the right place, at the right time, and with the right information is crucial, having the right people is even more important. But when it comes to the right people, skilled access experts from Axios work together with every other stakeholder to enable access for our patients. As an organization, Axios prioritizes growth, embraces change, and remains committed to the well-being of patients. The evolution from a consultancy firm to an implementation-focused entity has reshaped how the company operates and strengthened its impact.  

Axios believes in driving change through a people-first approach; therefore, people management and development are key priorities for Axios. With effective people, operational controls, and administrative and reporting procedures, Axios champions a better working environment by focusing on employee mental health and well-being. 

As we navigate the challenges of a diverse workforce, Axios continues to adapt and thrive, setting new standards for innovation and patient-centricity in the industry. 

15th March 2023

In recent years, digital health technologies have revolutionized how healthcare is delivered, providing patients with access to faster, more efficient, and more convenient care.

From Artificial Intelligence (AI) to Machine Learning (ML) to telemedicine, these technologies can potentially improve patient outcomes, reduce healthcare costs, and increase access to care for people worldwide.

In essence, AI simulates human intelligence and allows to process large amounts of apparently unconnected data by machines, especially computer systems. In healthcare, AI and ML solutions have increasingly become a part of the healthcare ecosystem and are transforming how healthcare is delivered. Also, since healthcare data is often fragmented and is present in various formats, by using AI and machine learning technologies, organizations can connect disparate data to get a more unified picture of the individuals behind the data. Likewise, machine learning is used to help medical professionals care for patients and manage clinical data.

With the help of machine power, we can provide user-centric experiences. Healthcare organizations can find insights faster and more accurately through improved efficiency in operations.

Telemedicine is also being increasingly used to allow doctors to make more data-driven, real-time decisions that may improve the patient experience and health outcomes by enabling them to work more toward virtual care alternatives throughout the care continuum. A case in point is how Covid-19 played a catalytic role in the increasing use of telemedicine during this time.

Predicting health outcomes

Another game-changing use of technology in healthcare is for predicting health outcomes. In medicine, AI is also deployed in predictive analytics to explore patient datasets and forecast the likelihood of certain diseases/disorders, which benefits both the patients and healthcare providers.

Healthcare digitalization can, thus, play an instrumental role in improving accessibility by complementing and even enhancing physical systems. It shifts the focus toward patient-centric care systems and helps healthcare providers make more strategic, informed decisions reaching patients wherever they are to provide better-quality care.

In the patient journey, predictive analysis is instrumental in the healthcare system and our ability to provide tailored comfortable patient care. Thanks to AI and ML, we can anticipate the influx of people, which in turn can support care center decision-makers in allocating the right healthcare staff to the right place at the right time.

With a focus on giving sustainable access to healthcare to patients, Axios International has created a comprehensive suite of digital tools that connect all stakeholders based on more than 25 years of specialized experience designing and managing Patient Support Programs (PSPs). Through the integrated Axios+ ecosystem, all parties communicate, interact, and work together to maximize patient support and health outcomes.

The conceptualization, development, and roll-out of Axios+ digital tools follow a traditional approach that involves a multi-stakeholder collaboration that strives towards a connected ecosystem and patient-centricity. The focus is then shifted to customizing the solution with global know-how to adapt to the local context and ensuring it is adopted across the value chain.

Axios+ aims to improve the medical outcomes of treatment by making it easy for patients to track and manage their therapy while facilitating and expediting the PSP referral process for physicians and the medication dispensing process for pharmacists.
Already, Axios+ has been rolled out in 22 countries and has impacted more than 14,500 patients in 90 programs. Over 3,140 physicians and 1,155 referring hospitals have used Axios+ so far. A recent Axios case study also shows that patients can get treatment up to 52 percent faster, allowing healthcare professionals to spend more time with more patients, eventually increasing their access to treatment.

Considering the healthcare disparities across the different countries regarding access to technology, education, or policies and framework, Axios+ Patient Management System remains the core of the Axios digital ecosystem, bridging patients to healthcare systems by going beyond healthcare facilities. However, multi-stakeholder collaboration is essential for improving access to treatment. All parties involved must want and be ready to transform into digital healthcare and start embracing the change.

As part of its strategy, Axios International already partners and seeks further collaboration with large digital companies and tech disruptors to build interconnectivity and help support patients in fulfilling their treatment journey with the ease and care they need. However, it is essential to note that digital is just an enabler that facilitates high interaction and engagement to support patients. The ecosystem must support and simplify human interactions rather than replace them.

5th January 2023

Where do patients go when they need care and treatment? Or where do patients go after being diagnosed with a chronic disease? Many of us would immediately think of a hospital or a medical facility. However, that can be costly, as it could involve a long wait, and be ineffective. In addition, it places more burden on an already-overtaxed part of the healthcare system that is still reeling from the aftermath of the Covid-19 pandemic.

The pandemic upended the entire health ecosystem. Hospitals had to reassign significant resources, time, and physical space to treat urgent cases. Unfortunately, despite the best efforts by providers, many patients in need of critical care and treatment for chronic diseases were left behind.

A new focus of care outside traditional settings was urgently required to provide access to patients needing post-acute and long-term care. The need of the hour is to develop an ecosystem that brings the necessary multidisciplinary healthcare provisions to the patient instead of bringing the patient to the provider.

Remote care alternatives and the adoption of innovative technology are an ideal combination to ensure adherence to treatment throughout the patient’s journey and deliver healthcare quickly. Solutions, including telehealth, remote patient monitoring (RPM), mobile clinics, and artificial intelligence (AI), will effectively treat patients and provide them with quality care from afar.

Improving the patient journey outside the healthcare facilities

Remote services have proven to provide a safe, convenient, and effective way to serve patients outside the hospital environment. Furthermore, it has also recently seen a rise in demand.

In 2019, Axios designed a cross-regional program spanning the UAE, KSA, and Kuwait. The program utilizes a team of government health agencies, pharmaceutical companies, physicians, pharmacies, and other stakeholders to help overcome the growing burden on traditional health facilities and help close the patient support gap that exists outside the hospital. The solution is centered around remote and at-home care customized to each patient’s needs.

The solution ensures eligible patients receive quality care, and sustainable support from Axios’ experienced, multidisciplinary team of healthcare professionals in the most convenient in a conducive setting, either at home, in a facility, or a combination of the two.

Virtual appointments with physiotherapists and nutritionists, delivery of prescribed treatments directly to a patient’s door, and home visits by a multidisciplinary team of specialists are among the many options continuously emerging to offer higher quality care at a better value for both the patient and the healthcare system.

The program has already proven popular among patients and practitioners. During the past two years, 25,000+ patients have been enrolled in the program, while 2,000+ healthcare practitioners have recommended patients and guided them through their treatment journey. Also, over 4,000 specialty medications have been delivered to about 1,400 patients, offering individuals a new way to continue their prescribed treatment without visiting a hospital or pharmacy.

Over 98 percent of patients that received care at home requested value added services during multidisciplinary team visits. In the UAE alone, over 26,000 different services have been conducted for patients during the past two years. Axios Remote Care services include receiving a full nutrition plan, physiotherapy, diagnostic and vaccination services at home, as well as completing IV drips. Axios Home Care is currently available across many countries in the MENA region, with plans for further expansion.

In the past 25 years, Axios’ has committed to advocating access solutions that strengthen the healthcare system and maximize medical benefits for patients.

Generating further interest, this year at the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT) 2023, Axios is conducting a scientific program on ‘The Impact of Access on Healthcare Efficiency,’ where Axios will engage and co-create conversations from different perspectives such as regulators, healthcare providers, private companies, societal and patients perspectives that will generate 360-degree point of views aimed at empowering the future of transforming accessibility to healthcare and increasing efficiency.

Photo caption: Axios International congratulates Cliona Brady (seated), Dr.Anas Nofal (left), and Roshel Jayasundera (right) on being promoted to top leadership positions at Axios. Cliona is now the Chief Operating Officer (COO). Anas and Roshel have now been promoted to Managing Partners. Our leaders play an active role in guiding the business by continuing to push boundaries to do what is right and embrace change. Axios wishes them all the best in their new roles!

Axios International, a global healthcare access company, is pleased to announce promotions in its global leadership team to support its strategic business initiatives.

With effect from January 1, 2023, Cliona Brady, Senior Director, Business Services, has been promoted to the position of Chief Operating Officer and will lead the strategic design and operational delivery of a global Business Services function, including Human Resources, Finance, IT, Compliance, Communications, and Corporate Governance. Anas Nofal, Senior Director of Greater Middle East and North Africa, and Roshel Jayasundera, Senior Director, Global Consulting, have both been promoted to the positions of Managing Partners and are responsible for guiding Axios’ strategic direction, developing and implementing organizational goals by managing Axios International’s diverse teams and client relationships worldwide.

Cliona, who joined Axios in 2009, helped restructure the foundation of Axios in the past 10 years and made it where it is today. In her new role, she will provide leadership and management to ensure that the business has effective people, operational controls, and administrative and reporting procedures in place. Anas joined in 2011 and started Axios’ first program in MENA. Today he has successfully developed the business and implemented innovative projects in all of Axios’ healthcare access and adherence programs and significantly expanded its footprint in the Greater Middle East and Africa regions. Roshel joined Axios in 2016 and has been instrumental in overseeing high-performing consulting services globally as well as operational teams in Latin America, Europe, Africa, and Asia.

Dr. Joseph Saba, Chief Executive Officer and Co-Founder of Axios International said, “As the company marked its 25^th anniversary and reached a critical size and footprint, strengthening one of our greatest assets – the Axios family is a priority. Our leaders play an active role in guiding the business by continuing to push boundaries, do what is right and never stand still in embracing change. Anas and Roshel will continue to nurture client and partners relationships roles and grow Axios footprint and impact in their new position as ‘Managing Partners,’ while Cliona will reinforce the internal teams in her role as the new ‘Chief Operating Officer.’ I look forward to continuing to work with them and believe they will be instrumental in successfully leading Axios toward the next 25 years of transforming access to healthcare. With our exceptionally strong senior leadership team in place, we will continue to focus on creating long-term value for our stakeholders, clients, and most importantly, our patients.”

Executive bios and photographs of the top leadership team at Axios are available here click link

Ends

“Malaysia, with regards to healthcare overall, is ahead of the game. Digital healthcare has been a strategic priority for them since the start,” says Roshel Jayasundera, Senior Director, Global Consulting.

Listen to learn more from our latest digital conference hosted in Malaysia titled, ‘The Role of Digital Healthcare in Providing Holistic Support Solutions Beyond the Hospital Setting.’ 

Join Roshel and Director of Digital Health, Raphael Itah, as they speak to Audrey Raj, host of the Business Station, BFM 89.9 in Malaysia, about the why digital healthcare is so crucial in Malaysia, and around the world, and how it can improve treatment outcomes.

With hundreds of healthcare leaders in attendance, we had a great time learning and sharing our insights during this week’s ASEAN HEALTHCARE TRANSFORMATION SUMMIT 2022 in Malaysia. Our Senior Director, Global Consulting, Roshel Jayasundera, and Director of Digital, Raphael Itah, shared learnings from our Patient Support Programs in Asia on leveraging technology in the connected health era.

We look forward to working with clients and partners across the region to help transform their approach to access and care delivery through digitalization.

Click here to download a report on digital trends in healthcare access.

Our Senior Director, Greater MENA, Anas Nofal joined an esteemed panel of experts at ISPOR SAUDI ARABIA to discuss the value of Patient Support Programs (PSPs) in driving positive medical outcomes for patients.

Anas shared learnings from our PSPs across the MENA region on how such programs can be used to enable patient and system-level cost savings, while improving medical outcomes.

The session was moderated by Dr. Abdullah Alanazi, Assistant Professor, Department of Clinical Pharmacy, and Director of the Health Sciences Research Unit at Al-Jouf University in Saudi Arabia.

Visit https://ispor-saudi.com/ for more information.

Our History

Axios was formed in 1997 by an entrepreneurial group of health experts who believed that patients deserved better. They shared a unique vision of an organization that would bring the distinct needs of the private and public sectors together to transform conventional access to healthcare models. And that’s exactly what we did.

At the peak of the HIV/AIDS pandemic, Axios founders designed and launched an unprecedented antiretroviral (ARV) access program at a time when access to quality medications in developing countries was unheard-of. Soon after, we launched the world’s first access programs for cancer medications.

Our early programs gave millions of patients access to critical, life-saving medications and opened the world’s eyes to the feasibility of alternative, more effective access models. 25 years later, Axios continues to break new ground in the design and implementation of access to healthcare solutions across Africa, Asia, Latin America, Middle East and Europe.

The Future of Access

There remains much uncharted territory to navigate and new opportunities to explore to improve patient access. As we look ahead to the next 25 years, we felt it was important to ensure that our brand reflected our learnings from the past two decades and served as a guide for the road ahead. That is why today Axios unveils a new logo. The globe in our new logo represents what we feel is needed to continue to improve access to healthcare for patients all around the world: Access is not a one-off solution. Sustainable access is multi-dimensional and built by addressing the needs of all involved stakeholders. The globe in our new logo represents the building blocks of sustainable access solutions.

Sustainable access solutions must:

• Blue: Support financial sustainability
• Orange: Drive patient outcomes
• Green: Enable health system and policy improvements

We look forward to continuing to collaborate with our clients and partners to put quality care and treatment within reach so that all people can achieve better health.